ACI's FDA Boot Camp Will Feature FDORA Updates this March

NEW YORK - Feb. 17, 2023 - PRLog -- The Food and Drug Omnibus Reform Act (FDORA) which was part of The Consolidated Appropriations Act for 2023 made some significant changes to core FDA regulations. American Conference Institute' s (ACI's) 40^th FDA Boot Camp will cover these changes.

Co-chairs, Kurt Karst and Stacey Cline Amin (a former FDA Chief Counsel) will lead an incredible faculty comprised of the "who's who" of the FDA Bar to explore the core essentials of FDA law and regulation, including the new amendments under FDORA. Key sessions will address FDORA amendments to accelerated approvals and clinical trial diversity.

Lisa J. Piccolo, AVP of Content and Strategy at ACI noted, "ACI has produced this conference for nearly two decades and have had the privilege of training top executives and counsel for the life sciences industry in core FDA competencies through our incredible faculty. We have not seen such significant chance since the Food and Drug Administration Amendments Act FDAAA in 2007. " Piccolo added, "We look forward to working with Kurt and Stacey on another informative and timely event."

Full information on the event, visit https://bit.ly/ACIsFDABootCamp

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Headquartered in New York, ACI has grown to produce more than 100 events each year, attended by thousands of senior delegates from across the world.